This article was originally published in The Rose Sheet
Sheila Cutner tapped president of Jurlique USA, effective immediately, Australian organic skin care company announces Oct. 17. Reporting to CEO Huy Truong, exec replaces Mark Wuttke, who is named to the newly-created international position of president, luxury spa division. Cutner plans to "quietly nurture" Jurlique's growing U.S. presence, which includes spa distribution as well as 14 U.S. independent retail locations, according to the firm. Exec was chosen because she has a "proven track record of conceptualizing how to grow a brand and how to successfully work with an international structure," company notes. Most recently, Cutner served as VP of marketing and public relations at LVMH...
You may also be interested in...
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.